Tatiana Efimenko

Dr. Tatiana Efimenko

Gause Institute of New Antibiotics, Moscow, Russia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Molecular Cell
Verified
Journal Article
Closed access
YPYury S. Polikanov
Yury S. Polikanov
IOIlya Osterman
Ilya Osterman
TSTeresa Szal
Teresa Szal
VTVadim N. Tashlitsky
Vadim N. Tashlitsky
MSMarina Serebryakova
Marina Serebryakova
PSPetr Sergiev
Petr Sergiev

15 October 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
OKOlga Kisil
Olga Kisil
TETatiana Efimenko
Tatiana Efimenko
OEOlga Vladimir Efremenkova
Olga Vladimir Efremenkova
The emergence of antibiotic-resistant pathogenic bacteria in recent decades leads us to an urgent need for the development of new antibacterial agents. The species of the genus Amycolatopsis are known as producers of secondary metabolites that are used in medicine and agriculture. The complete genome sequences of the Amycolatopsis demonstrate a wide variety of biosynthetic gene clusters, which highlights the potential ability of actinomycetes of this genus to produce new antibiotics. In this review, we summarize information about antibiotics produced by Amycolatopsis species. This knowledge demonstrates the prospects for further study of this genus as an enormous source of antibiotics.

27 October 2020 in Acta Naturae
Verified
Journal Article
Open access
PDF file
OKOlga Kisil
Olga Kisil
TETatiana Efimenko
Tatiana Efimenko
NGNina I. Gabrielyan
Nina I. Gabrielyan
OEOlga Vladimir Efremenkova
Olga Vladimir Efremenkova
The spread of antibiotic resistance among pathogens represents a threat to human health around the world. In 2017, the World Health Organization published a list of 12 top-priority antibiotic-resistant pathogenic bacteria for which new effective antibiotics or new ways of treating the infections caused by them are needed. This review focuses on Acinetobacter baumannii, one of these top-priority pathogens. The pathogenic bacterium A. baumannii is one of the most frequently encountered infectious agents in the world; its clinically significant features include resistance to UV light, drying, disinfectants, and antibiotics. This review looks at the various attempts that have been made to tackle the problem of drug resistance relating to A. baumannii variants without the use of antibiotics. The potential of bacteriophages and antimicrobial peptides in the treatment of infections caused by A. baumannii in both planktonic and biofilm form is assessed. Such topics as research into the development of vaccines based on the outer membrane proteins of A. baumannii and the use of silver nanoparticles, as well as photodynamic and chelate therapy, are also covered.

7 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AKAnastasia Kuvarina
Anastasia Kuvarina
IGIrina A. Gavryushina
Irina A. Gavryushina
MSMaxim Sukonnikov
Maxim Sukonnikov
TETatiana Efimenko
Tatiana Efimenko
NMNatalia Markelova
Natalia Markelova
VSVera Sadykova
Vera Sadykova
Features of the biochemical adaptations of alkaliphilic fungi to exist in extreme environments could promote the production of active antibiotic compounds with the potential to control microorganisms, causing infections associated with health care. Thirty-eight alkaliphilic and alkalitolerant Emericellopsis strains (E. alkalina, E. cf. maritima, E. cf. terricola, Emericellopsis sp.) isolated from different saline soda soils and belonging to marine, terrestrial, and soda soil ecological clades were investigated for emericellipsin A (EmiA) biosynthesis, an antifungal peptaibol previously described for Emericellopsis alkalina. The analysis of the Emericellopsis sp. strains belonging to marine and terrestrial clades from chloride soils revealed another novel form with a mass of 1032.7 Da, defined by MALDI-TOF Ms/Ms spectrometers, as the EmiA lacked a hydroxyl (dEmiA). EmiA displayed strong inhibitory effects on cell proliferation and viability of HCT 116 cells in a dose- and time-dependent manners and induced apoptosis.

1 September 2018 in Microbiology
Verified
Journal Article
Closed access
PDF file
TETatiana Efimenko
Tatiana Efimenko
OEOlga Vladimir Efremenkova
Olga Vladimir Efremenkova
EDE. V. Demkina
E. V. Demkina
MPM. A. Petrova
M. A. Petrova
ISI. G. Sumarukova
I. G. Sumarukova
GEG. I. El’-Registan
G. I. El’-Registan
— Nontraditional sources were shown to be promising for obtaining bacterial isolates characterized by efficient production of antibiotics, including those affecting the strains with multidrug...

29 October 2018 in Antibiotics
Verified
Journal Article
Open access
PDF file
AGAlla A. Glukhova
Alla A. Glukhova
AKAnna A. Karabanova
Anna A. Karabanova
AYAndrey Yakushev
Andrey Yakushev
ISIrina I. Semenyuk
Irina I. Semenyuk
YBYuliya V. Boykova
Yuliya V. Boykova
OEOlga Vladimir Efremenkova
Olga Vladimir Efremenkova
Because of the spread of drug resistance, it is necessary to look for new antibiotics that are effective against pathogenic microorganisms. The purpose of this study was to analyse the species composition of actinobacteria isolated from the digestive tract of the millipedes Nedyopus dawydoffiae and to determine their antimicrobial properties. Species identification was carried out on the basis of the morphological and culture properties and the sequence of the 16S rRNA gene. Actinobacteria were grown in different liquid media. Antibiotic properties were determined against some Gram-positive and Gram-negative bacteria as well as fungi. Of the 15 isolated strains, 13 have antibiotic activity against Gram-positive bacteria (including methicillin-resistant Staphylococcus aureus—MRSA) and fungi, but there was no antibiotic activity against Gram-negative test strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. It was established that antibiotic-producing actinobacteria belong to eight species of the genus Streptomyces. Depending on the nutrient medium, actinobacteria demonstrate different antimicrobial activities. As an example, S. hydrogenans shows that even strains selected in one population differ by the range of antimicrobial activity and the level of biosynthesis. Since the antibiotic production is considered as a feature for species competition in the microbiota community, the variability of antibiotic production among different strains of the same species is an adaptive characteristic for the competition in millipedes’ digestive tract community.